United States Federal Circuit

In a patent dispute concerning a system for the transdermal administration of fentanyl, the district court correctly concluded that plaintiff's patent 1) was neither anticipated nor obvious to another patent, and 2) is not unenforceable due to inequitable conduct.

Appellate Information

• Decided 12/10/2004
• Published 12/10/2004

Judges

• Before NEWMAN, Circuit Judge, ARCHER, Senior Circuit Judge, and DYK, Circuit Judge.

Court

• United States Federal Circuit

Counsel

• For Appellees:
  
• Gregory L. Diskant, Patterson, Belknap, Webb & Tyler LLP, of New York, New York, argued for plaintiffs-appellees.   With him on the brief was Jeffrey I.D. Lewis., E. Anthony Figg, Rothwell, Figg, Ernst & Manbeck, of Washington, DC, argued for defendants-appellants.   With him on the brief were Joseph A. Hynds and Sharon L. Davis.